Hormonal Approach for Postmenopausal Vulvovaginal Atrophy [PDF]
Menopause is a physiological and progressive phenomenon secondary to decreased ovarian follicular reserve that significantly affects the genital tract. Although postmenopausal vulvovaginal atrophy primarily affects postmenopausal women, it is also seen ...
Ana Paula Ferreira Costa +7 more
doaj +7 more sources
GRACE-trial: a randomised active-controlled trial for vulvovaginal atrophy in patients with breast cancer on endocrine therapy – study protocol [PDF]
Introduction Breast cancer is the most common cancer type in women worldwide. Due to hormone receptor positivity in the majority of the breast cancer tumours is endocrine therapy a crucial part in the treatment landscape of breast cancer.
Glenn Vergauwen +6 more
doaj +4 more sources
Lubricants application in vulvovaginal atrophy [PDF]
Lubricants application in vulvovaginal atrophy Yu.E. Dobrokhotova, S.A. Khlynova Pirogov Russian National Research Medical University, Moscow, Russian Federation Interim periods as well as the postmenopausal period are extremely important in ...
Yu.E. Dobrokhotova, S.A. Khlynova
doaj +3 more sources
Vulvovaginal atrophy during menopause [PDF]
Objective: To present a basic clinical research based on current evidence about advanced treatment methods for vulvovaginal atrophy during menopause.And on principles of management of patients with vulvovaginal atrophy.Vulvovaginal atrophy (VVA) is a ...
Orru, A.J.
core +3 more sources
Use of Moisturizers and Lubricants for Vulvovaginal Atrophy [PDF]
The estrogen decrease in postmenopausal women results in functional and anatomical changes in the genitourinary tract. The most prevalent and bothersome symptoms are vaginal dryness, dyspareunia, and reduced lubrication, which can significantly affect ...
Ayane Cristine Alves Sarmento +7 more
doaj +6 more sources
Impact Of Vulvovaginal Atrophy Of Menopause In Spanish Women: Prevalence And Symptoms According To The EVES Study [PDF]
Introduction: The prevalence of menopausal women with confirmed vulvovaginal atrophy (VVA) oscillates between 67–98%. Aim: To assess the prevalence of postmenopausal women with VVA confirmed by gynecologic clinical assessment among all women attending ...
Santiago Palacios, MD, PhD +27 more
doaj +4 more sources
Safety and Feasibility of Autologous Micro-Fragmented Adipose Tissue Injections for the Treatment of Vaginal Atrophy, Vulvovaginal Dystrophy, and Stress Urinary Incontinence: An Observational Case Series [PDF]
Objective: Vaginal atrophy, vulvovaginal dystrophy, and stress urinary incontinence (SUI), common conditions in women, have detrimental effects on quality of life.
Laura Stark +5 more
doaj +2 more sources
Vulvovaginal atrophy: current methods of diagnosis and treatment
Aim. To review modern methods of diagnosis and treatment of vulvovaginal atrophy (VVA), which is one of the manifestations of genitourinary syndrome of menopause in periand postmenopausal women.Materials and methods.
L. F. Zainetdinova +3 more
doaj +4 more sources
Vulvovaginal atrophy in the peri- and post-menopause: relevance and impact on quality of life [PDF]
Vulvovaginal atrophy (VVA) is detected in more than 50% of postmenopausal women, and at 4049 years of age, 15-19% of women have relevant signs. Atrophic changes in the female urogenital system are associated with hypoestrogenism, which results in the ...
Mekan R. Orazov +5 more
doaj +3 more sources
Diagnostics and management of vulvovaginal atrophy according to the international guidelines
Vulvovaginal atrophy is one of the genitourinary symptoms caused by estrogen deficiency which leads to the development of immature vaginal epithelium, glycogen deficiency, reduction or even elimination of lactobacilli, and secondary genitourinary tract ...
K. V. Dmitrienko +2 more
doaj +3 more sources

